HLA-G and pregnancy adverse outcomes

Medical Hypotheses

Volumn 76, Issue 6, 2011, Pages 782-784

  Cecati, Monia ^a   Giannubilo, Stefano R ^a   Emanuelli, Monica ^a   Tranquilli, Andrea L ^a   Saccucci, Franca ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; ISOPROTEIN;

ADVERSE OUTCOME; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; DNA POLYMORPHISM; FETOPLACENTAL UNIT; FRAMESHIFT MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOTHESIS; PREECLAMPSIA; PREGNANCY OUTCOME; SPONTANEOUS ABORTION; TROPHOBLAST;

FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 79955730704     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.02.017     Document Type: Article

References (19)

1. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248(4952):220-223.
2. King A., Boocock C., Sharkey A.M., Gardner L., Beretta A., Siccardi A.G., et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996, 156(6):2068-2076.
3. Fuji T., Ishitani A., Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994, 153(12):5516-5524.
4. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6 and -G7 transcripts in human transfected cells. Hum Immunol 2000, 61(11):1138-1149.
5. Park G.M., Lee S., Park B., Kim E., Shin J., Cho K., et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated lysis. Biochem Biophys Res Commun 2004, 313(3):606-611.
6. Suárez M.B., Morales P., Castro M.J., Fernández V., Varela P., Alvarez M., et al. A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Immunogenetics 1997, 45(6):464-465.
7. Ober C., Aldrich C., Rosinsky B., Robertson A., Walker M.A., Willadsen S., et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998, 19(2-3):127-132.
8. Aldrich C., Verp M.S., Walker M.A., Ober C. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation. J Reprod Immunol 2000, 47:41-48.
9. O'Brien M., Dausset J., Carosella E.D., Moreau P. Analysis of the role of HLA-G in preeclampsia. Hum Immunol 2000, 61:1126-1131.
10. Goldman-Wohl D.S., Ariel I., Greenfield C., Hochner-Celnikier D., Cross J., Fisher S., et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000, 6:88-95.
11. Rizzo R., Andersen A.S., Lassen M.R., Sørensen H.C., Bergholt T., Larsen M.H., et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009, 62(5):320-338.
12. Menier C., Guillard C., Cassinat B., Carosella E.D., Rouas-Freiss N. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera. Leukemia 2008, 22(3):578-584.
13. Passamonti F., Randi M.L., Rumi E., Pungolino E., Elena C., Pietra D., et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. Blood 2007, 110(2):485-489.
14. Barbui T., Finazzi G. Myeloproliferative disease in pregnancy and other management issues. Hematol Am Soc Hematol Educ Prog 2006, 246-252.
15. Robinson S., Bewley S., Hunt B.J., Radia D.H., Harrison C.N. The management and outcome of pregnancies in women with polycythemia vera. Haematologica 2005, 90(11):1477-1483.
16. Ruschitzka F.T., Wenger R.H., Stallmach T., Quaschning T., de Wit C., Wagner K., et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 2000, 97(21):11609-11613.
17. Gassmann M., Manini A., Stallmach T., Saam B., Kuhn G., Grenacher B., et al. Abortion in mice with excessive erythrocytosis is due to impaired arteriogenesis of the uterine arcade. Biol Reprod 2008, 78(6):1049-1057.
18. Gupta G., Gupta I., Suri V., Dhawan V., Ganguly N.K. Estimation of cord blood erythropoietin in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2000, 71(1):1-5.
19. Tranquilli A.L., Landi B. The origin of preeclampsia: from decidual " hyperoxia" to late hypoxia. Med Hypotheses 2010, 75(1):38-46.